scispace - formally typeset
A

Annemarei Ranta

Researcher at University of Otago

Publications -  99
Citations -  5992

Annemarei Ranta is an academic researcher from University of Otago. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 15, co-authored 81 publications receiving 3504 citations. Previous affiliations of Annemarei Ranta include University of Virginia & Auckland City Hospital.

Papers
More filters
Journal ArticleDOI

Global, regional, and national burden of neurological disorders, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016

Valery L. Feigin, +270 more
- 01 Nov 2017 - 
TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors (GBD) study provides such information but does not routinely aggregate results that are of interest to clinicians specialising in neurological conditions as discussed by the authors.
Journal ArticleDOI

Global, regional, and national burden of neurological disorders during 1990-2015

Valery L. Feigin, +241 more
Journal ArticleDOI

Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016

Valery L. Feigin, +215 more
TL;DR: In 2016, the global lifetime risk of stroke from the age of 25 years onward was approximately 25% among both men and women, and there was geographic variation in the lifetime risk, with the highest risks in East Asia, Central Europe, and Eastern Europe.
Journal ArticleDOI

Five insights from the Global Burden of Disease Study 2019

Christopher J L Murray, +866 more
- 17 Oct 2020 - 
TL;DR: Five key insights that are important for health, social, and economic development strategies have been distilled are distilled and are subject to the many limitations outlined in each of the component GBD capstone papers.
Journal ArticleDOI

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

Philip M.W. Bath, +514 more
- 20 Dec 2017 - 
TL;DR: Among patients with recent cerebral ischaemia, intensive antiplatelet therapy did not reduce the incidence and severity of recurrent stroke or TIA, but did significantly increase the risk of major bleeding.